Equities

Eom Pharmaceutical Holdings Inc

IMUC:PKL

Eom Pharmaceutical Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.124
  • Today's Change0.045 / 56.76%
  • Shares traded1.11k
  • 1 Year change-55.71%
  • Beta0.3978
Data delayed at least 15 minutes, as of Sep 20 2024 18:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2021202120202017
OPERATIONS
Net income(5.15)(1.45)(14)
Depreciation/depletion----0.05
Non-Cash items2.510.08(4.88)
Cash taxes paid, supplemental000
Cash interest paid, supplemental0.0100
Changes in working capital0.330.142.47
Total cash from operations(2.31)(1.24)(17)
INVESTING
Capital expenditures----0
Other investing and cash flow items, total----0.00
Total cash from investing----0.00
FINANCING
Financing cash flow items1.0300
Total cash dividends paid------
Issuance (retirement) of stock, net01.5012
Issuance (retirement) of debt, net2.500--
Total cash from financing3.531.5012
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash1.220.26(4.81)
Net cash-begin balance/reserved for future use0.26011
Net cash-end balance/reserved for future use1.490.266.63
SUPPLEMENTAL INCOME
Depreciation, supplemental----0.05
Cash interest paid, supplemental0.0100
Cash taxes paid, supplemental000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.